Navigation Links
GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
Date:11/10/2008

EBx(R) technology, to manufacture the MVA component of GeoVax's

HIV-1 vaccine. The breakthrough manufacturing technology developed

by Vivalis, through further development collaboration with GeoVax,

will create a new standard for manufacture of the MVA component of

GeoVax's HIV/AIDS vaccine. Vivalis' EBx(R) manufacturing platform,

with its increased effectiveness, superior quality and reliability,

is expected to better provide for MVA vaccine product availability

in ample quantities to meet sizeable demand and at a lesser cost.

Vivalis' vaccine manufacturing technology is based on a duck

embryonic stem cell substrate platform. Specifically, the EB66(R)

cell line provides continuous growth from a fully characterized

frozen cell bank, without necessitating fertilized embryo extraction

and processing, as with present chicken cell based technologies.

Furthermore, the EB66(R) cell line can be grown in suspension

(without the cells attached to the surface of the growth vessel) and

can be scaled up for growth in large bioreactors for commercial-

scale production of the MVA viral vaccine. The details of the final

license agreement between the parties are being negotiated and

GeoVax expects the final agreement to be executed before the end of

the year.

"On the financing front," Dr. McNally noted, "we are pleased with the financing strategy provided by the $10 million common stock purchase agreement with Fusion Capital Fund II, LLC, from which we are drawing in a judicious manner, and we are also benefiting greatly from government support in two ways -- from both the 5 year $15 million grant (approximately $3 million awarded annually) initially awarded in October 2007 by the National Institutes of Health, and also from ongoing clinical trial
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
2. U.S. Government Awards $15 Million Grant to GeoVax Labs HIV/AIDS Vaccine Program
3. GeoVax Further Strengthens Management Team
4. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
5. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
6. GeoVax Presents Data at AIDS Vaccine 2008 Conference
7. GeoVaxs DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... University of Minnesota electrical engineering researchers have developed ... time demonstrates mechanical transportation of light. The discovery ... more efficient optical devices for computation and communication. ... electrical and computer engineering assistant professor Mo Li ... published online and will appear in the October ...
(Date:9/22/2014)... Lawrence Livermore National Laboratory Director ... Friday renewed their institutional commitment by signing a ... to expand the collaborative work in the areas ... energy and environmental sciences. , This renewal represents ... in December 2009 and is a framework to ...
(Date:9/22/2014)... YORK , Sept. 22, 2014 US ... US demand for specialty biocides is forecast to rise ... In volume terms, demand is projected to increase 1.3 ... same period. A strong rebound in construction expenditures will ... paint and coatings markets, while growth in consumer spending ...
(Date:9/22/2014)... Jose, California (PRWEB) September 22, 2014 ... Chitin and chitosan are natural biopolymers available in ... extracted from easily available resources such as shells ... and chitosan is mainly due to the high ... cellulose. Chitosan finds application in various industries owing ...
Breaking Biology Technology:Engineers show light can play seesaw at the nanoscale 2Lawrence Livermore Renews Pact with Georgetown University to Expand Research and Education in Science and Policy 2US Biocides Market 2US Biocides Market 3Emergence of New Application Areas to Drive the Global Chitin and Chitosan Market, According to New Report by Global Industry Analysts, Inc. 2Emergence of New Application Areas to Drive the Global Chitin and Chitosan Market, According to New Report by Global Industry Analysts, Inc. 3
... , , INDIANAPOLIS, Sept. 2 ... announced that, effective October 1, 2009, it would increase the ... kg for all non-contract customers or as existing contracts permit. ... invest in expanding global supply for the high performance, reducing ...
... WILMINGTON, Delaware, September 2 According ... (2009 - 2014), published,by MarketsandMarkets ( http://www.marketsandmarkets.com ), ... US$19.4 billion by 2014, recording,a CAGR of 89.1% ... patients,insurers, and government agencies to reduce the costs ...
... , SOUTH PLAINFIELD, N.J., Sept. 2 ... and licensing agreement with Roche for the development of orally bioavailable ... (GEMS(TM)). The collaboration focuses initially on four CNS disease targets ... (Logo: http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO ) , , ...
Cached Biology Technology:MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014 2MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014 3PTC Therapeutics Announces Drug Discovery Collaboration With Roche 2PTC Therapeutics Announces Drug Discovery Collaboration With Roche 3
(Date:9/21/2014)... researchers has developed a protein therapy that disrupts the ... original tumor sites, travel through the blood stream and ... This process, known as metastasis, can cause cancer to ... patients who succumb to cancer fall prey to metastatic ... professor of bioengineering who describes a new therapeutic approach ...
(Date:9/19/2014)... fairness did not evolve for the sake of fairness ... of continued cooperation, so say Frans de Waal, PhD, ... about inequity aversion (IA), which is defined as a ... in Science . , Their conclusion comes ... to address their hypothesis that it is the evolution ...
(Date:9/18/2014)... new GSA Bulletin study uses tree rings ... and Chaco Wash in northern New Mexico, USA. By ... and willow, investigators were able to precisely date arroyo ... combined this data with aerial imagery, LiDAR, longitudinal profiles, ... arroyos. , Arroyos are deep, oversized channels that have ...
Breaking Biology News(10 mins):Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7
... build tannins, complex chemicals used by plants for defence ... discovered organelle that is found in most land plants. ... they are single-celled organisms like amoeba, or enormous entities ... up the body of the organism). Although cells may ...
... University of Alberta have made a basic science discovery ... When DNA becomes too damaged it ultimately leads to ... Glover and his colleagues published their findings in the ... summer. For years, scientists thought two key proteins involved ...
... landmark study that has discovered four novel gene variations ... meta-analysis, involving nearly 30,000 African-Americans, also found that the ... pressure across other populations. Epidemiology and biostatistics ... paper, which appears in The American Journal of ...
Cached Biology News:New cell component important to tea and wine-making 2Discovery about DNA repair could lead to improved cancer treatments 2African-American study identifies 4 genetic variants associated with blood pressure 2
FluoSpheres® biotin-labeled microspheres, 0.2 µm, yellow-green fluorescent (505/515) *1% solids*...
GM130 Immunogen: Recombinant purified rat GM130 Family / Subclass 1: Signal Transduction Storage: 4 C...
... Anti-NY-ESO-1, clone E978 ... : NM_001327 Immunogen ... protein Formulation: mouse ascites ... Quality Assurance: routinely evaluated ...
R26.4C...
Biology Products: